- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15.05. | AbbVie bags first approval for cancer ADC Emrelis | ||
| 15.05. | Sanofi pledges a $20 billion investment programme in the US | ||
| 15.05. | RFK Jr defends HHS cuts, measles stance in Congress hearings | ||
| 14.05. | EC's von der Leyen loses bid to stop disclosure of Pfizer texts | ||
| 14.05. | Novo makes fresh obesity play with $2.2bn Septerna deal | ||
| 14.05. | GSK pays $1.2bn for liver drug as it culls TIGIT programme | ||
| 14.05. | Call goes out for feedback on US health deregulation | ||
| 14.05. | UnitedHealth CEO Andrew Witty steps down | ||
| 14.05. | UnitedHealth CEO Chris Witty steps down | ||
| 13.05. | Digital support reduces GLP-1 dose needed for weight loss | ||
| 13.05. | Bayer CEO confident firm can cope with Xarelto hit | ||
| 13.05. | Galapagos drops plan to split after 'market developments' | ||
| 13.05. | Azafaros bags €132m for rare neuro-metabolic disorder drugs | ||
| 13.05. | Novo Nordisk builds case for Norditropin successor | ||
| 12.05. | Digital therapy for Tourette syndrome backed for NHS use | ||
| 12.05. | UK approves AZ inhaler with 'greener' propellant | ||
| 12.05. | Could an AI for biological age guide cancer treatment? | ||
| 12.05. | More data backs Zepbound over Wegovy for weight loss | ||
| 12.05. | More data back Zepbound over Wegovy for weight loss | ||
| 12.05. | Trump says he will tie US drug prices to other countries | ||
| 09.05. | Vor Bio winding down as multiple biotechs downsize | ||
| 09.05. | GSK reveals data behind linerixibat for PBC 'relentless itch' | ||
| 09.05. | AZ plots wider Imfinzi use in bladder cancer after trial win | ||
| 09.05. | Pharma still in waiting mode after UK-US trade agreement | ||
| 08.05. | FDA announces generative AI pilot and rapid rollout plans |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .